• Sandoz Sweden launches Vitaros®, an innovative new patent-protected therapy for leading urology disorder erectile dysfunction (ED)
• First topical therapy approved for treatment of ED, characterized by ease of use, rapid onset and high tolerability
• Launch demonstrates Sandoz commitment to meeting unmet medical need across key therapeutic areas, including Women’s and Men’s Health

Holzkirchen, August 4, 2014 – Sandoz, the generic pharmaceuticals division of Novartis, today announces the launch in Sweden of Vitaros®, an innovative new topical …